An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic Disease

Anemia of Chronic Disease Clinical Trial

Official title:
An Open-label Trial of an Erythropoietin Stimulating System to Determine Increased Red Blood Cell Production in Subjects Diagnosed With Anemia of Chronic Disease

Status Not yet recruiting

Clinical Trial Summary

The objective of this study is to measure the change in blood values after the administration of an amino acid based erythropoietin stimulating system.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01846689
Study type	Interventional
Source	Targeted Medical Pharma
Contact	Stephanie Pavlik, CRA
Phone	310-474-9809
Email	spavlik@ptlcentral.com
Status	Not yet recruiting
Phase	Phase 3
Start date	June 2013
Completion date	September 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05217836` - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Completed	`NCT01691040` - Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Cancer	Phase 2
Completed	`NCT01988116` - Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney Disease	Phase 0
Terminated	`NCT01873534` - A Phase 2A Trial of FMX-8 Treatment for Anemia in Patients With ESRD on Hemodialysis HD	Phase 2
Terminated	`NCT03528564` - Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia	Phase 2
Completed	`NCT01522794` - Pharmacokinetics/Pharmacodynamics of NOX-H94 in the Human Endotoxemia Model	Phase 1
Not yet recruiting	`NCT04071067` - Anemia of Inflammation and Deficiency Anemia